Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19.

ABSTRACT:

Introduction/aims

Coronavirus disease-2019 (COVID-19) may have a more severe course in patients with myasthenia gravis (MG). We aimed to assess severity of the infection and factors contributing to its severity in a group of MG patients, most of whom were not hospitalized.

Methods

One hundred forty outpatients with MG followed between March 2020 and April 2021 were included in our study. Patients were asked to respond to a brief questionnaire in person, by telemedicine, or through electronic messages.

Results

Nineteen patients tested positive for COVID-19 by polymerase chain reaction. Two were asymptomatic. Of the 17 symptomatic patients, 11 had mild symptoms. They either had no treatment or received antivirals, antibiotics, and anticoagulants. Their myasthenia was we

SUBMITTER: Gungor Tuncer O 

PROVIDER: S-EPMC9015549 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature